GLP-1 Agonists and Cancer: Risks Explained
In recent years, glucagon-like peptide 1 receptor agonists (GLP1RAs) have emerged as a transformative class of therapeutics for managing type ...
Tag: GLP-1 receptor agonists and cancer risk
Examining the Link Between GLP-1 Receptor Agonists and Cancer Risk in Adults with Obesity
In a groundbreaking retrospective cohort study published in the highly respected journal JAMA Oncology, researchers have unveiled compelling evidence that ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!